Crinetics Pharmaceuticals, Inc. (CRNX)
84.95
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
Crinetics Pharmaceuticals Cash from Operations (Annual) : -377.92M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -377.92M |
| December 31, 2024 | -230.19M |
| December 31, 2023 | -166.31M |
| December 31, 2022 | -115.20M |
| December 31, 2021 | -88.59M |
| Date | Value |
|---|---|
| December 31, 2020 | -62.03M |
| December 31, 2019 | -46.38M |
| December 31, 2018 | -19.46M |
| December 31, 2017 | -9.479M |
| December 31, 2016 | -5.468M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.631B |
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Bristol Myers Squibb Co. | 14.16B |
| Corcept Therapeutics, Inc. | 142.00M |